Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_provenance.
- NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_assertion description "[PEG-ADA is a long-circulating form of adenosine deaminase (ADA) that has been in use for > 8 years as replacement therapy for severe combined immunodeficiency disease due to ADA deficiency.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_provenance.
- NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_assertion evidence source_evidence_literature NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_provenance.
- NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_assertion SIO_000772 7749407 NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_provenance.
- NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_assertion wasDerivedFrom befree-20140225 NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_provenance.
- NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_assertion wasGeneratedBy ECO_0000203 NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_provenance.